← back to search

Matthias Schiemann

Technical University of Munich · DE
Area of research
Immunology · Oncology
Research interest
Research interests include Biology, CD8, Adoptive cell transfer, Stem cell, Cancer research, and Immunology.
h-index
citations
1,600
works
16
NIH funding
primary concept
email

Recent publications

Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, <scp>EMT</scp> nor metastatic spread in colorectal cancer
The Journal of Pathology Clinical Research 2022cited by 8position: middledoi
Fate mapping of single NK cells identifies a type 1 innate lymphoid-like lineage that bridges innate and adaptive recognition of viral infection
Immunity 2021cited by 81position: middledoi
Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression
Scientific Reports 2021cited by 33position: middledoi
Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress
Blood 2021cited by 19position: middledoi
TAMEP are brain tumor parenchymal cells controlling neoplastic angiogenesis and progression
Cell Systems 2021cited by 10position: middledoi
Early emergence of T central memory precursors programs clonal dominance during chronic viral infection
Nature Immunology 2020cited by 65position: middledoi
Secreted factors from mouse embryonic fibroblasts maintain repopulating function of single cultured hematopoietic stem cells
Haematologica 2020cited by 3position: middledoi
AN IMPORTANT STIMULATORY ROLE FOR THE cGMP-DEPENDENT PROTEIN KINASE II IN PLATELET ACTIVATION, IN VIVO THROMBOSIS AND HAEMOSTASIS
2020cited by 1position: middledoi
Distinct Surface Expression of Activating Receptor Ly49H Drives Differential Expansion of NK Cell Clones upon Murine Cytomegalovirus Infection
Immunity 2019cited by 71position: middledoi
Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT
Leukemia 2017cited by 160position: middledoi
T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice
Gastroenterology 2015cited by 94position: middledoi
Serial Transfer of Single-Cell-Derived Immunocompetence Reveals Stemness of CD8+ Central Memory T Cells
Immunity 2014cited by 314position: middledoi
Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy
Blood 2014cited by 107position: middledoi
Disparate Individual Fates Compose Robust CD8 <sup>+</sup> T Cell Immunity
Science 2013cited by 420position: middledoi
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
Hepatology 2013cited by 168position: middledoi
MHC Multimer-Guided and Cell Culture-Independent Isolation of Functional T Cell Receptors from Single Cells Facilitates TCR Identification for Immunotherapy
PLoS ONE 2013cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dirk H. Busch · German Center for Infection Research7 papers (2013–2021)Veit R. Buchholz · Marymount University6 papers (2013–2021)Michael Floßdorf · Technical University of Munich5 papers (2013–2021)Thomas Höfer · Roche (Switzerland)4 papers (2013–2021)Lynette Henkel · Technical University of Munich3 papers (2013–2020)Sophie Flommersfeld · Technical University of Munich3 papers (2019–2021)Ludwig O. Pachmayr · Technical University of Munich3 papers (2019–2021)Inge Hensel · Technical University of Munich3 papers (2013–2021)Luka Čičin‐Šain · Medizinische Hochschule Hannover3 papers (2019–2021)Justin Leube · Technical University of Munich3 papers (2019–2021)Simon Grassmann · Technical University of Munich3 papers (2019–2021)Patricia Graef · Technical University of Munich2 papers (2014–2014)Julia Albrecht · Technical University of Munich2 papers (2013–2014)Lorenz Kretschmer · Technical University of Munich2 papers (2013–2020)Lorenz Mihatsch · Technical University of Munich2 papers (2019–2020)Georg Dössinger · Technical University of Munich2 papers (2013–2014)Martin F. Sprinzl · Johannes Gutenberg University Mainz2 papers (2013–2015)Florian Bassermann · TUM Klinikum2 papers (2020–2021)M. Zeeshan Chaudhry · University of Queensland2 papers (2020–2021)Katharina S. Götze · German Cancer Research Center2 papers (2020–2021)